Prevalence, growth rate and complications of splenic artery aneurysms in chronic liver disease patients
Abstract
Summary:Background: Chronic liver disease (CLD) patients are at greater risk for developing splenic artery aneurysm (SAA). Treatment for aneurysms > 2.5 cm in this population is considered. However, the procedure might be challenging in CLD patients, and complications may interfere in liver transplantation. We, therefore, sought to estimate the prevalence, growth rate and complications of SAA in patients with CLD. As secondary objective, we sought to evaluate whether those features differ in pre and post transplantation follow-up and among aneurysms with diameters greater or less than 2.5 cm at diagnosis. Patients and methods: We searched for the terms “SAA” and “CLD” on CT or MRI reports from January 2009 to December 2016. Patients with single examination or less than 6 months follow-up were excluded. Results: Fifty nine out of 2050 CLD patients presented SAA (prevalence of 2.9%). Fifteen patients were excluded (due to exclusion criteria). Forty-four CLD patients (mean age 55.9 years) presented 76 SAA (follow-up median of 27.2 months). Aneurysms presented mean size of 1.5 ± 0.74 cm at diagnosis and growth rate of 0.12 ± 0.14 cm/y. Two (4.5%) patients presented mild complications (aneurysm thrombosis). No significant differences were observed in the growth rates of aneurysms < 2.5 cm and ≥ 2.5 cm or in the initial size and growth rates of aneurysms of patients submitted to and not submitted to liver transplantation. Conclusions: The estimated prevalence of SAA in patients with DLC in the Brazilian population is 2.9% (CI95% 2.2–3.6%). Although SAA in CLD patients are less likely to remain stable and grow faster than in general population, aneurysms are usually diagnosed at smaller size and complications are rare. These findings might support conservative management with close surveillance, especially in smaller aneurysms.
References
1 Characteristics and management of splenic artery aneurysms in adult living donor liver transplant recipients. Liver Transpl. 2009;15:1535–41.
2 Splenic artery aneurysms: two decades experience at Mayo clinic. Ann Vasc Surg. 2002;16:442–9.
3 Covered stenting and transcatheter embolization of splenic artery aneurysms in diabetic patients: A review of endovascular treatment of visceral artery aneurysms in the current era. Pharmacol Res. 2018;135:127–35.
4 Editor’s Choice - Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017;53:460–510.
5 The Society for Vascular Surgery clinical practice guidelines on the management of visceral aneurysms. J Vasc Surg. 2020;72:3S–39S.
6 . Splenic artery aneurysm rupture in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2009;146:133–7.
7 . The management of splenic artery aneurysm in patients awaiting liver transplantation. Clin Transplant. 2010;24:691–4.
8 . Management of splenic artery aneurysms: the significance of portal and essential hypertension. J Am Coll Surg. 1999;189:483–90.
9 Visceral artery aneurysms in liver transplant candidates and in patients after liver transplantation. PLoS One. 2011;6:e29544.
10 . Splenic artery aneurysms in portal hypertension. J Cardiovasc Surg. 1982;23:490–3.
11 . Splenic artery aneurysms in liver transplant patients. Transplantation. 1988;45:386–9.
12 . The recognition and incidence of splenic artery aneurysms. Australas Radiol. 1974;18:432–8.
13 . Splenic artery aneurysm and orthotopic liver transplantation. Transpl Int. 1999;12:68–70.
14 The development and clinical features of splenic aneurysm associated with liver cirrhosis. Liver Int. 2006;26:291–7.
15 . Prevalence and predictive factors for development of splenic artery aneurysms in cirrhosis. Indian J Gastroenterol. 2016;35:201–6.
16 , Splenic artery aneurysms in liver transplant patients. Liver Transplant Group. J Hepatol. 1997;27:890–3.
17 . Aneurysm of the splenic artery. Gut. 1960;1:312–20.
18 . Abnormal splenic artery diameter/hepatic artery diameter ratio in cirrhosis-induced portal hypertension. World J Gastroenterol. 2013;19:1292.
19 . Spleen-preserving surgery in splenic artery aneurysm. Case Rep Surg. 2017;2017:1–4.
20 Burden of chronic viral hepatitis and liver cirrhosis in brazil – the Brazilian Global Burden of Disease Study. Ann Hepatol. 2017;16:893–900.
21 Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort. Ann Hepatol. 2014;13:386–93.
22 A systematic review and meta-analysis of the management of visceral artery aneurysms. J Vasc Surg. 2019;70(5):1694–9.
23 Natural history and management of splanchnic artery aneurysms in a single tertiary referral center. J Vasc Surg. 2018;68(4):1079–87.
